Hormone therapy not associated with fracture risk in young transgender women (1)

16 Sept 2019


A Dutch study published in the Journal of Bone and Mineral Research finds no link between hormone therapy and fracture risk among young transgender women, but a potentially higher risk in trans women over the age of 50.

Healio


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story